Wells Fargo’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $472K | Buy |
72,567
+18,871
| +35% | +$123K | ﹤0.01% | 3831 |
|
|
2025
Q1 | $426K | Buy |
53,696
+1,961
| +4% | +$15.6K | ﹤0.01% | 3787 |
|
|
2024
Q4 | $655K | Sell |
51,735
-4,744
| -8% | -$60.1K | ﹤0.01% | 3546 |
|
|
2024
Q3 | $787K | Sell |
56,479
-457
| -0.8% | -$6.37K | ﹤0.01% | 3343 |
|
|
2024
Q2 | $785K | Buy |
56,936
+11,175
| +24% | +$154K | ﹤0.01% | 3325 |
|
|
2024
Q1 | $756K | Buy |
45,761
+7,536
| +20% | +$124K | ﹤0.01% | 3293 |
|
|
2023
Q4 | $558K | Sell |
38,225
-39,386
| -51% | -$575K | ﹤0.01% | 3441 |
|
|
2023
Q3 | $952K | Sell |
77,611
-13,350
| -15% | -$164K | ﹤0.01% | 3122 |
|
|
2023
Q2 | $1.09M | Buy |
90,961
+33,403
| +58% | +$399K | ﹤0.01% | 3232 |
|
|
2023
Q1 | $770K | Buy |
57,558
+36,837
| +178% | +$493K | ﹤0.01% | 3336 |
|
|
2022
Q4 | $446K | Sell |
20,721
-258
| -1% | -$5.55K | ﹤0.01% | 3484 |
|
|
2022
Q3 | $420K | Buy |
20,979
+767
| +4% | +$15.4K | ﹤0.01% | 3560 |
|
|
2022
Q2 | $362K | Buy |
20,212
+10,212
| +102% | +$183K | ﹤0.01% | 3708 |
|
|
2022
Q1 | $99K | Sell |
10,000
-652
| -6% | -$6.46K | ﹤0.01% | 5016 |
|
|
2021
Q4 | $180K | Buy |
10,652
+599
| +6% | +$10.1K | ﹤0.01% | 4951 |
|
|
2021
Q3 | $238K | Buy |
+10,053
| New | +$238K | ﹤0.01% | 4744 |
|